1. Academic Validation
  2. Novel A-ring and B-ring modified combretastatin A-4 (CA-4) analogues endowed with interesting cytotoxic activity

Novel A-ring and B-ring modified combretastatin A-4 (CA-4) analogues endowed with interesting cytotoxic activity

  • J Med Chem. 2008 Oct 9;51(19):6211-5. doi: 10.1021/jm8005004.
Daniele Simoni 1 Romeo Romagnoli Riccardo Baruchello Riccardo Rondanin Giuseppina Grisolia Marco Eleopra Michele Rizzi Manlio Tolomeo Giuseppe Giannini Domenico Alloatti Massimo Castorina Marcella Marcellini Claudio Pisano
Affiliations

Affiliation

  • 1 Dipartimento di Scienze Farmaceutiche, Università di Ferrara, Ferrara, Italy. smd@unife.it
Abstract

A novel class of combretastatins, modified at A-ring or both A- and B-rings, mainly by replacement with benzofuran or benzo[b]thiophene, were synthesized. The new heterocombretastatins showed good cytotoxic activity on BMEC and H-460 cell lines. The aminocombretastatin 9f potently inhibits cell growth of BMEC and combretastatin-resistant HT-29 cell lines, with potential interest to treat colon carcinoma. Heterocombretastatins 9a,b inhibit tubulin polymerization similarly to CA-4 by having a binding to colchicine site five times stronger.

Figures